FDA Inspection 1330806 — Lorenza Landi
The FDA completed an inspection of Lorenza Landi on Jul 24, 2026 in Rome. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rome (Italy)
Additional Details
Clinical Investigator (CI)